Factors That May Affect Bone Density During GLP-1 Treatment While GLP-1 medications themselves may not directly cause bone loss, several factors associated with their use warrant consideration, particularly the significant weight loss many patients experience
You will have a consult with one of our providers
Beyond the medication cost itself, consider the cost of supplies
We believe this system provides a foundation for gene- and cell-based therapeutic applications that require once-daily therapeutic dosing
Eli Lilly has direct-to-consumer pharmacy programs where Zepbound, in vial and syringe form, can be purchased for $300$450 per month, depending on the dose. Other branded GLP-1s may fall into a lower range through manufacturer programs
Of note, there was also an increased rate of amputation noted for unknown mechanisms [23]